ARCHIVES

BMI May Be Prognostic Tool For Types Of Breast Cancer

This article is from The Cancer Letter archive.

Vol. 31 No. 3 | March 28, 2008

Download PDF Visit The Full Archive

Related Articles

Professional Fundraiser Poses Eight Questions For SU2C 3.

September 19, 2008

GPC Biotech’s Satraplatin Fails To Extend Survival In Hormone-Refractory Prostate Cancer.

November 2, 2007

ODAC Recommends Iressa Approval As Third-Line Lung Cancer Treatment

September 27, 2002

Hearing Probes CDC On Cancer Treatment For Working Poor In Screening Program

July 23, 1999

Litton Wins FCRF Research Contract, Harland Land Animal Protections

September 17, 1982

Academies Updates Guidelines on Stem Cell Research. NIH Begins New T-R01 Program.

September 19, 2008